Pour, L., Szarejko, M., Bila, J., Schjesvold, F. H., Spicka, I., Maisnar, V., Jurczyszyn, A., Grudeva-Popova, Z., Hájek, R., Usenko, G., Thuresson, M., Norin, S., Jarefors, S., Bakker, N. A., Richardson, P. G. and Mateos, M.-V. (2024) “Efficacy and safety of melflufen plus daratumumab and dexamethasone in relapsed/refractory multiple myeloma: results from the randomized, open-label, phase III LIGHTHOUSE study”, Haematologica. Pavia, Italy, 109(3), pp. 895-905. doi: 10.3324/haematol.2023.283509.